15 citations
,
  July 2016   in “Urologic Clinics of North America”    Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.  
     
           15 citations
,
  November 2015   in “Pharmacopsychiatry”    α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.  
        Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.  
     
           22 citations
,
  January 2018   in “European urology focus”    New drugs and combination therapies are improving treatment for lower urinary tract symptoms.  
     
           March 2024   in “Cleveland Clinic journal of medicine”    Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.